Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 3

Sponsor Class

INDUSTRY 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Sarcoma 2Plasma cell 1Other hematologic neoplasm 1Genitourinary 1Breast 1

Conditions

Glioma 2Central Nervous System Neoplasms 2Brain Neoplasms 2Sarcoma 1Gliosarcoma 1Glioblastoma 1Astrocytoma 1

Interventions

Temozolomide 299Radiotherapy 219Bevacizumab 139Carboplatin 91Cyclophosphamide 88Etoposide 82Filgrastim 72Vincristine 69Irinotecan 69Magnetic Resonance Spectroscopy 65Cisplatin 59Radiation 58Radiosurgery 52Surgical Procedures, Operative 41Peripheral Blood Stem Cell Transplantation 40Topotecan 39Doxorubicin 39Lomustine 37Carmustine 36sargramostim 35Granulocyte Colony-Stimulating Factor 35Melphalan 34Nivolumab 32Chemotherapy, Adjuvant 32Radiotherapy, Intensity-Modulated 29Isotretinoin 29Everolimus 29Erlotinib Hydrochloride 27Thiotepa 25Vorinostat 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Leflunomide × CNS × Clear all
NCT00003775 2012-09-13

Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse

Pfizer

Phase 2 Completed
60 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioma, Central Nervous System Neoplasms

NCT00003293 2012-09-11

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

Pfizer

Phase 3 Completed
CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00001573 2008-03-04

A Phase I Study of SU101 in Pediatric Patients With Refractory Malignancy

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
30 enrolled
CNSSarcoma

Glioma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡